Zobrazeno 1 - 10
of 242
pro vyhledávání: '"Barbara Schulz"'
Publikováno v:
Fungal Biology and Biotechnology, Vol 10, Iss 1, Pp 1-12 (2023)
Abstract Background Due to the infection with the invasive ascomycete Hymenoscyphus fraxineus, which has been replacing the closely related and non-pathogenic native Hymenoscyphus albidus, the European ashes, Fraxinus excelsior (also known as the com
Externí odkaz:
https://doaj.org/article/72deb70aef8e4c129086c42f30d7b4c7
Autor:
Özge Demir, Haoxuan Zeng, Barbara Schulz, Hedda Schrey, Michael Steinert, Marc Stadler, Frank Surup
Publikováno v:
Biomolecules, Vol 13, Iss 11, p 1632 (2023)
A fungal endophyte originating from the Canary Islands was identified as a potent antagonist against the fungal phytopathogen Hymenoscyphus fraxineus, which causes the devastating ash dieback disease. This endophyte was tentatively identified as Pezi
Externí odkaz:
https://doaj.org/article/2f4c51a02ae549df8c91ed732386832d
Autor:
Laure Gossec, Philip J Mease, Xenofon Baraliakos, Laura C Coates, Helena Marzo-Ortega, Effie Pournara, Barbara Schulz, Roisin White, Eamonn O’Brien
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objectives To investigate patient characteristics predictive of response to secukinumab in patients with psoriatic arthritis (PsA) with axial manifestations.Methods In a post-hoc analysis from the MAXIMISE trial (NCT02721966) in patients with PsA and
Externí odkaz:
https://doaj.org/article/59466151ecd64fc4a58046b5177ac525
Autor:
Denis Poddubnyy, Effie Pournara, Agnieszka Zielińska, Asta Baranauskaite, Alejandro Muñoz Jiménez, Sanchayita Sadhu, Barbara Schulz, Michael Rissler, Chiara Perella, Helena Marzo-Ortega
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Background: This study aimed to evaluate the efficacy and safety of secukinumab 150 mg compared with placebo in the management of spinal pain and disease activity in patients with axial spondyloarthritis (axSpA) at Week 8 and up to Week 24. Methods:
Externí odkaz:
https://doaj.org/article/0aab8dcaba324ec297f20dbdc50890f5
Autor:
Hidayat Hussain, Ahmed Al-Harrasi, Karsten Krohn, Simeon F. Kouam, Ghulam Abbas, Afzal Shah, Muhammad Adil Raees, Riaz Ullah, Shahid Aziz, Barbara Schulz
Publikováno v:
Journal of King Saud University: Science, Vol 27, Iss 4, Pp 375-378 (2015)
Different fractions of root and stem of Derris scandens demonstrated good antibacterial (Escherichia coli, and Bacillus megaterium), antialgal (Chlorella fusca), and antifungal (Microbotryum violaceum) activities. Phytochemical investigation resulted
Externí odkaz:
https://doaj.org/article/4bd2794341eb49f18d5ceb96d170b233
Autor:
Ramona Riclea, Julia Gleitzmann, Hilke Bruns, Corina Junker, Barbara Schulz, Jeroen S. Dickschat
Publikováno v:
Beilstein Journal of Organic Chemistry, Vol 8, Iss 1, Pp 941-950 (2012)
Volatiles released by the marine Roseobacter clade bacterium Rugeria pomeroyi were collected by use of a closed-loop stripping headspace apparatus (CLSA) and analysed by GC–MS. Several lactones were found for which structural proposals were derived
Externí odkaz:
https://doaj.org/article/aad610a6c3964bb6b1cd7b014613eead
Publikováno v:
ARKIVOC, Vol 2012, Iss 6, Pp 71-89 (2012)
Externí odkaz:
https://doaj.org/article/8025c85eca0e48e48e94275718960ba9
Autor:
Uta Kiltz, Petros P. Sfikakis, Karl Gaffney, Andreas Bounas, Nicola Gullick, Eric Lespessailles, Jan Brandt-Juergens, Rasho Rashkov, Barbara Schulz, Effie Pournara, Piotr Jagiello
Publikováno v:
Rheumatology and Therapy. 9:1129-1142
Introduction: Sustained improvement of high degree in clinical outcomes have been demonstrated in phase 3 trials with secukinumab in both psoriatic arthritis (PsA) and ankylosing spondylitis (AS). The objective of the SERENA study was to evaluate the
Autor:
Xenofon Baraliakos, Effie Pournara, Laura C Coates, Victoria Navarro-Compán, Ricardo Blanco, Eamonn O’Brien, Barbara Schulz, Robert Landewe
Objective The current analysis of the MAXIMISE trial was conducted to investigate the presence of post-inflammatory and degenerative spinal changes and inflammatory changes in spinal processes identified in baseline MRIs and their potential for predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4105721aec155d5446bbeab63980be40
https://doi.org/10.1093/rheumatology/kead162
https://doi.org/10.1093/rheumatology/kead162
Autor:
Helena Marzo-Ortega, Denis Poddubnyy, Effie Pournara, Barbara Schulz, Atul Deodhar, Xenofon Baraliakos
Publikováno v:
Rheumatology. 61
Background/Aims Human Leukocyte Antigen (HLA)-B is strongly associated with axial spondyloarthritis (axSpA); over 100 subtypes of HLA-B27 are currently recognized and designated as HLA-B∗2701 to HLA-B∗27106. The association of these subtypes with